GSK-376501
- Generic Name
- GSK-376501
- Drug Type
- Small Molecule
- Chemical Formula
- C32H37NO6
- CAS Number
- 1010412-80-2
- Unique Ingredient Identifier
- 7511RY999U
- Background
GSK376501 has been used in trials studying the treatment and diagnostic of Type 2 Diabetes Mellitus.
Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 23
- Registration Number
- NCT00615212
- Locations
- 🇺🇸
GSK Investigational Site, Buffalo, New York, United States
A Drug Interaction Study Between Simvastatin and GSK376501
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 39
- Registration Number
- NCT00605449
- Locations
- 🇺🇸
GSK Investigational Site, Austin, Texas, United States
Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2007-07-02
- Last Posted Date
- 2010-10-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 70
- Registration Number
- NCT00495014
- Locations
- 🇺🇸
GSK Investigational Site, Evansville, Indiana, United States
A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2006-11-29
- Last Posted Date
- 2017-01-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 72
- Registration Number
- NCT00404963
- Locations
- 🇺🇸
GSK Investigational Site, Evansville, Indiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath